Dizal Pharma
Suzhou, China Specialty Founded 2016 201-500 employees
Chinese CRO-turned-biotech providing clinical development services with deep oncology expertise, operating a portfolio of discovery through Phase III programs in solid tumors and hematological malignancies.
Services
Therapeutic Areas
Certifications
Regulatory Experience
NMPAFDA